Method for implementing a staple system

A method of preparing a staple cartridge, the method comprising:

• forming first staples with a first alloy, wherein the first staples comprise a material configured to deliver a treatment therapy into a tissue environment within a patient, the material comprising a doped alloy comprising an alpha particle emitter;
• forming second staples with a second alloy that is different than the first alloy;
• positioning the first staples into staple cavities of a first row of staple cavities of the staple cartridge, wherein the first row of staple cavities is a first distance from an elongate slot of the staple cartridge;
• and
• positioning the second staples into staple cavities of a second row of staple cavities, wherein the second row of staple cavities is a second distance from the elongate slot of the staple cartridge, wherein the second distance is greater than the first distance.

A method of preparing a staple cartridge, the method comprising:

• forming first staples with a first alloy, wherein the first staples comprise a material configured to deliver radiotherapy into a tissue environment within a patient, the material comprising a doped alloy comprising an alpha particle emitter;
• coating the first staples with a first coating;
• forming second staples with a second alloy that is different than the first alloy;
• coating the second staples with a second coating that is the same as the first coating;
• positioning the first staples into staple cavities of a first row of staple cavities of the staple cartridge, wherein the first row of staple cavities is a first distance from an elongate slot of the staple cartridge;
• and
• positioning the second staples into staple cavities of a second row of staple cavities, wherein the second row of staple cavities is a second distance from the elongate slot of the staple cartridge, wherein the second distance is greater than the first distance;
• wherein the first staples are configured to degrade at a first rate in the tissue environment within the patient, and wherein the second staples are configured to degrade at a second rate in the tissue environment that is different than the first rate.